Rankings
▼
Calendar
PRGO Q4 2023 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena
PRGO
Perrigo Company plc
$1B
Q4 2023 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$1.2B
+0.1% YoY
Gross Profit
$427M
36.9% margin
Operating Income
-$16M
-1.3% margin
Net Income
-$32M
-2.8% margin
EPS (Diluted)
$-0.24
QoQ Revenue Growth
+2.9%
Cash Flow
Operating Cash Flow
$209M
Free Cash Flow
$182M
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$10.8B
Total Liabilities
$6.0B
Stockholders' Equity
$4.8B
Cash & Equivalents
$751M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.2B
$1.2B
+0.1%
Gross Profit
$427M
$383M
+11.7%
Operating Income
-$16M
$31M
-150.3%
Net Income
-$32M
-$24M
-36.3%
Revenue Segments
Consumer Self-Care Americas
$744M
64%
Consumer Self-Care International
$413M
36%
Geographic Segments
UNITED STATES
$741M
63%
Europe
$390M
33%
Other Geographical Areas
$27M
2%
IRELAND
$10M
1%
← FY 2023
All Quarters
Q1 2024 →